Axol Biosciences Announces CiPA-Validated Human Stem Cell-Derived Ventricular Cardiomyocytes June 8, 2022 Auto Bot News 0 Axol Biosciences’ CiPA-validated ventricular cardiomyocytes can be used as a robust cardiotoxicity measurement tool.